AUG 20, 2018 10:20 AM PDT

Antidepressants Restore Inhibitory Neurons in Mice

WRITTEN BY: Nouran Amin

The capacity of brain cells to change is referred to as "plasticity” and according to a new study a decline in plasticity is associated with sensory and cognitive decline from the process of normal brain aging.

 

Now, scientists at MIT's Picower Institute for Learning and memory showed that inhibitory interneurons in the visual cortex of mice remained equally abundant during aging however, their arbors are more simplified and less dynamic.

Fortunately, the research study published in the Journal of Neuroscience explains that a significant degree of plasticity loss in mice was restored eventually using an antidepressant drug. The antidepressant drug is very common and known as “Prozac”.

Image Credit: CloudFront.net

Antidepressants work to ameliorate the age-related decline in the structural and functional plasticity of the visual cortex neurons. Despite common belief, loss of neurons due to cell death is quite limited during normal aging and unlikely to account for age-related functional impairments," the scientists explained including lead author of the study, Ronen Eavri. "Rather it seems that structural alterations in neuronal morphology and synaptic connections are features most consistently correlated with brain age, and may be considered as the potential physical basis for the age-related decline.

"Our finding that fluoxetine treatment in aging mice can attenuate the concurrent age-related declines in interneuron structural and visual cortex functional plasticity suggests it could provide an important therapeutic approach towards mitigation of sensory and cognitive deficits associated with aging, provided it is initiated before severe network deterioration.”

Source: Picower Institute at MIT

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Anti-Hypertensive Drug Use and Dementia?
A soon to be published study investigated the relationship between antihypertensive drug use and dementia in older adults. The study derived data from the ...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
'Sugar-coating' proteins to treat pancreatitis?
A powerful biomarker created by complex sugar molecules, called CA19-9, may be a target for the treatment of pancreatitis. Pancreatitis is an inflammatory ...
SEP 16, 2019
Genetics & Genomics
SEP 16, 2019
Combination Therapy Eliminates HIV From Rodent Model
In 2017, 1.8 million new cases of HIV infection were diagnosed around the world, and around 37 million people live with the virus....
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Maintenance of Shelf-Stable Drugs
In a study published in the Proceedings of the National Academy of Sciences, scientists have designed a mathematical model that illustrates how some drugs ...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Drug Targets Early Instigators of Alzheimer Disease
The two solidifying instigators of Alzheimer -disease (AD)—amyloid beta and the tau protein—have long been the topic of study for AD researcher...
SEP 16, 2019
Immunology
SEP 16, 2019
A New Way To Fight Severe Peanut Allergies
Dr. Sandra Lin explains how SLIT is currently being used to treat allergies other than peanuts.    Over 1 million U.S. children have an allergy t...
Loading Comments...